CBP-CON-00179

Active
Federal

CSL BEHRING (AUSTRALIA) PTY LTD

Awarded by National Blood Authority

The National Blood Authority has a limited-tender contract with CSL BEHRING (AUSTRALIA) PTY LTD valued at AU$1,874,602,218 for the national supply arrangement for imported immunoglobulin products. The contract runs from December 2020 to December 2027 and has one amendment. The limited tender was exempted under TR 10.3.d.iii due to an absence of competition for technical reasons.

$1.9B
Contract Value

Contract Details

Reference
CN3743070
Jurisdiction
Federal
Financial Year
FY26
Category
Drugs and Pharmaceutical(UNSPSC: 51000000)

Description

National Supply arrangement for imported immunoglobulin products

Key Dates

Publish Date
9 June 2026
Effective Date
31 Dec 2020
End Date
30 Dec 2027

Published fields

Procurement method
Limited tender
Location
Not published in this source

Supplier

Agency

National Blood Authority

ABN
87 361 602 478

Contract History

This contract has been amended 1 time.

Original Contract
Published 19 Jan 2021
$806.8M
Amendment A1
Current
Published 9 June 2026
$1.9B